Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter L Stern

Showing results (11-20 of 90) with videos related to

Pageof 9
Sort By:
Cancer Immunology, Immunotherapy : CII|October 21, 2016
5T4 oncofoetal antigen: an attractive target for immune intervention in cancerPeter L Stern, Richard Harrop
Viruses|July 2, 2021
Oropharyngeal Squamous Cell Carcinoma Treatment in the Era of Immune Checkpoint InhibitorsPeter L Stern, Tina Dalianis
Papillomavirus Research (Amsterdam, Netherlands)|April 14, 2019
Opportunities to improve immune-based prevention of HPV-associated cancersPeter L Stern, Richard Bs Roden
Therapeutic Advances in Vaccines and Immunotherapy|January 10, 2019
The failure of radical treatments to cure cancer: can less deliver more?Angus G Dalgleish, Peter L Stern
Stem Cells (Dayton, Ohio)|September 28, 2002
The human cytomegalovirus immediate-early promoter is transcriptionally active in undifferentiated mouse embryonic stem cellsChristopher M Ward, Peter L Stern
Therapeutic Advances in Vaccines|August 11, 2017
Human papillomavirus-driven immune deviation: challenge and novel opportunity for immunotherapySigrun Smola, Connie Trimble, Peter L Stern
Nature Reviews. Cancer|March 3, 2018
Opportunities and challenges for human papillomavirus vaccination in cancerRichard B S Roden, Peter L Stern
Therapeutic Advances in Vaccines and Immunotherapy|February 6, 2019
Cancer stem cell mobilization and therapeutic targeting of the 5T4 oncofetal antigenRichard Harrop, Eric O'Neill, Peter L Stern
Expert Opinion on Biological Therapy|March 21, 2008
Immunotherapy for gastrointestinal cancer: current status and strategies for improving efficacyEyad Elkord, Robert E Hawkins, Peter L Stern
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 12, 2002
The use of vaccines in the prevention and treatment of cervical cancerEmma J Davidson, Henry C Kitchener, Peter L Stern
Pageof 9

Showing results (11-20 of 90) with videos related to

Sort By:
Pageof 9
Cancer Immunology, Immunotherapy : CII|October 21, 2016
5T4 oncofoetal antigen: an attractive target for immune intervention in cancerPeter L Stern, Richard Harrop
Viruses|July 2, 2021
Oropharyngeal Squamous Cell Carcinoma Treatment in the Era of Immune Checkpoint InhibitorsPeter L Stern, Tina Dalianis
Papillomavirus Research (Amsterdam, Netherlands)|April 14, 2019
Opportunities to improve immune-based prevention of HPV-associated cancersPeter L Stern, Richard Bs Roden
Therapeutic Advances in Vaccines and Immunotherapy|January 10, 2019
The failure of radical treatments to cure cancer: can less deliver more?Angus G Dalgleish, Peter L Stern
Stem Cells (Dayton, Ohio)|September 28, 2002
The human cytomegalovirus immediate-early promoter is transcriptionally active in undifferentiated mouse embryonic stem cellsChristopher M Ward, Peter L Stern
Therapeutic Advances in Vaccines|August 11, 2017
Human papillomavirus-driven immune deviation: challenge and novel opportunity for immunotherapySigrun Smola, Connie Trimble, Peter L Stern
Nature Reviews. Cancer|March 3, 2018
Opportunities and challenges for human papillomavirus vaccination in cancerRichard B S Roden, Peter L Stern
Therapeutic Advances in Vaccines and Immunotherapy|February 6, 2019
Cancer stem cell mobilization and therapeutic targeting of the 5T4 oncofetal antigenRichard Harrop, Eric O'Neill, Peter L Stern
Expert Opinion on Biological Therapy|March 21, 2008
Immunotherapy for gastrointestinal cancer: current status and strategies for improving efficacyEyad Elkord, Robert E Hawkins, Peter L Stern
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 12, 2002
The use of vaccines in the prevention and treatment of cervical cancerEmma J Davidson, Henry C Kitchener, Peter L Stern
Pageof 9